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SUMMARY The concentrations of somatostatin and choline acetyl transferase (CAT) were measured in nine brains from patients with progressive supranuclear palsy (PSP) and compared with those obtained from 19 matched control brains. In PSP, CAT activity was reduced in the caudate nucleus and limbic areas (amygdala, hippocampus and cingulate cortex) but was not different from controls in neocortical areas (frontal and temporal). Somatostatin concentrations were not different from controls in any region tested. In contrast to Alzheimer's disease and Parkinson's disease, intellectual deterioration in PSP is not associated with a deficit in neocortical somatostatin and CAT levels.
Senile dementia of Alzheimer type (SDAT) is associated with cortical neuronal loss, histopathological stigmata such as neurofibrillary tangles and neuritic plaques,t and decrease in somatostatin levels,2 a peptide which is known to be contained in intrinsic neurons. This model of so-called "cortical dementia"3 is also associated with lesions of subcortical areas particularly of the substantia innominata from which originates the cholinergic innervation of the cortex. Degeneration of this subcortico-cortical neurotransmitter system may contribute to intellectual impairment in patients. 4 Parkinson's disease mainly characterised by marked cell loss in the substantia nigra shares clinical, anatomical and biochemical features with SDAT:the subcortico-cortical cholinergic system is affected5 and the severity of the cholinergic deficit has been related to intellectual deterioration.5 6 Neurons in the cerebral cortex probably degenerate in the demented Parkinsonians since histopathological
The aim of the present study was to test whether dementia is also associated with cortical cholinergic and somatostatinergic deficits in progressive supranuclear palsy (PSP), a paradigm for "subcortical dementia" (see 8 for review). In PSP, the massive neuronal degeneration in the basal ganglia and upper brainstem contrasts with the absence of gross lesions in the cerebral cortex.8 The severe frontal lobe-like syndrome has been attributed to "frontal deafferentation" through interruption of the basal ganglia output towards the frontal area.8 In contrast to SDAT and Parkinson's disease, the subcorticocortical dopaminergic,9 noradrenergic, serotoninergic,'0 and cholinergic9 10 systems seem mainly spared.
Material and methods
Nineteen control brains from subjects with no known neurological or psychiatric diseases and nine brains from patients with clinically and histopathologically diagnosed PSP9 were examined. Intellectual deterioration was diagnosed on the basis of retrospective analysis of case histories and refers to a constellation of symptoms (slowness of ide- 
